Detalhe da pesquisa
1.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Oncologist
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38815151
2.
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Oncologist
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38873934
3.
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
Pediatr Blood Cancer
; 71(3): e30817, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189770
4.
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(4): 541-550, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192573
5.
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Cancer
; 126(24): 5303-5310, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914879
6.
Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
Pediatr Blood Cancer
; 67(9): e28334, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608575
7.
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
Pediatr Blood Cancer
; 67(2): e28073, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724813
8.
Essential medicines for childhood cancer in Europe.
Lancet Oncol
; 24(2): e67, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725147
9.
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).
Cancer
; 124(23): 4548-4555, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30394521
10.
Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.
Invest New Drugs
; 31(1): 39-45, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22669335
11.
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
Pediatr Blood Cancer
; 60(4): 627-32, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23002039
12.
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
J Natl Cancer Inst
; 115(11): 1355-1363, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228094
13.
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.
J Neurooncol
; 106(3): 643-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21968943
14.
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412.
Clin Cancer Res
; 28(23): 5088-5097, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190525
15.
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
J Clin Oncol
; 40(20): 2235-2245, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363510
16.
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
J Clin Oncol
; 40(20): 2224-2234, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353553
17.
Educational paper. The development of new therapies for pediatric oncology.
Eur J Pediatr
; 170(5): 555-9, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21190039
18.
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1.
Cancer Chemother Pharmacol
; 88(2): 359-365, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023919
19.
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).
Clin Cancer Res
; 27(13): 3543-3548, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568345
20.
Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.
Pediatr Blood Cancer
; 55(1): 119-22, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20486176